Robert Wong

5.1k total citations · 1 hit paper
78 papers, 3.7k citations indexed

About

Robert Wong is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Robert Wong has authored 78 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 29 papers in Hematology and 20 papers in Immunology. Recurrent topics in Robert Wong's work include Autoimmune and Inflammatory Disorders Research (29 papers), Spondyloarthritis Studies and Treatments (25 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). Robert Wong is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (29 papers), Spondyloarthritis Studies and Treatments (25 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). Robert Wong collaborates with scholars based in United States, Germany and Netherlands. Robert Wong's co-authors include H. Küpper, Désirée van der Heijde, Joachim Sieper, John C. Davis, Jürgen Braun, Walter P. Maksymowych, Michael Schiff, Alan Kivitz, Ben A. C. Dijkmans and Maxime Dougados and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Diabetes.

In The Last Decade

Robert Wong

76 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

2006 660 citations Désirée van der Heijde, Joachim Sieper et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Wong United States	30	2.6k	1.7k	1.0k	289	256	78	3.7k
A. H. Zwinderman Netherlands	26	1.8k 0.7×	581 0.4×	666 0.6×	433 1.5×	263 1.0×	48	4.0k
P. T. Dawes United Kingdom	32	1.9k 0.7×	533 0.3×	560 0.5×	231 0.8×	331 1.3×	100	3.0k
Johanna M. W. Hazes Netherlands	29	2.0k 0.8×	1.2k 0.7×	787 0.8×	288 1.0×	364 1.4×	81	3.6k
Emília Inoue Sato Brazil	33	2.0k 0.8×	1.0k 0.6×	322 0.3×	265 0.9×	237 0.9×	125	3.2k
Francisco Carmona Spain	38	733 0.3×	989 0.6×	253 0.2×	440 1.5×	185 0.7×	188	4.3k
Jordi Gratacós Spain	33	2.3k 0.9×	1.4k 0.8×	803 0.8×	285 1.0×	320 1.3×	186	3.2k
R. B. M. Landewé Netherlands	22	5.0k 1.9×	2.1k 1.2×	1.8k 1.7×	313 1.1×	350 1.4×	65	5.7k
Linda T. Hiraki Canada	20	1.7k 0.6×	849 0.5×	358 0.3×	119 0.4×	137 0.5×	65	2.2k
Riccardo Melicòni Italy	33	1.6k 0.6×	593 0.4×	218 0.2×	341 1.2×	448 1.8×	137	3.5k
Markku Korpela Finland	34	2.7k 1.0×	679 0.4×	693 0.7×	317 1.1×	472 1.8×	86	4.0k

Countries citing papers authored by Robert Wong

Since Specialization

Citations

This map shows the geographic impact of Robert Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wong more than expected).

Fields of papers citing papers by Robert Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wong. The network helps show where Robert Wong may publish in the future.

Co-authorship network of co-authors of Robert Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Wong. A scholar is included among the top collaborators of Robert Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Wong. Robert Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Younossi, Zobair M., Giacomo Germani, Robert Wong, et al.. (2025). Steatotic liver disease is the dominant indication for liver transplantation in both Europe and the United States: Trends and outcomes in the past 2 decades. Liver Transplantation. 32(4). 549–557. 1 indexed citations

Emery, Paul, R. Fleischmann, Robert Wong, et al.. (2025). Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study. The Journal of Rheumatology. 52(5). 426–435.

Emery, Paul, Yoshiya Tanaka, Vivian P. Bykerk, et al.. (2023). Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis. Rheumatology and Therapy. 10(3). 707–727. 6 indexed citations

Brunner, Hermine I., Nikolay Tzaribachev, Ingrid Louw, et al.. (2023). Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept. Arthritis Care & Research. 75(11). 2259–2266. 1 indexed citations

Emery, Paul, Yoshiya Tanaka, Vivian P. Bykerk, et al.. (2023). The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study. Arthritis Research & Therapy. 25(1). 67–67. 1 indexed citations

Ruperto, Nicolino, Hermine I. Brunner, Nikolay Tzaribachev, et al.. (2021). Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 48(7). 1073–1081. 4 indexed citations

Baer, Alan N., Jacques‐Eric Gottenberg, E. William St. Clair, et al.. (2020). Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial. Annals of the Rheumatic Diseases. 80(3). 339–348. 81 indexed citations

Brunner, Hermine I., Robert Wong, Marleen Nys, et al.. (2020). Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis. Pediatric Drugs. 22(6). 653–672. 9 indexed citations

Revicki, Dennis A., Anne M. Rentz, Michelle P. Luo, & Robert Wong. (2011). Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis. Health and Quality of Life Outcomes. 9(1). 36–36. 34 indexed citations

10.

Maksymowych, Walter P., Katherine Gooch, Maxime Dougados, et al.. (2010). Thresholds of patient‐reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics. Arthritis Care & Research. 62(6). 826–834. 33 indexed citations

11.

Rudwaleit, Martín, Pascal Claudepierre, Martina Kron, et al.. (2010). Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis. Arthritis Research & Therapy. 12(2). R43–R43. 27 indexed citations

12.

Choy, Ernest, D. Gladman, Christopher T. Ritchlin, et al.. (2009). IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING ADALIMUMAB, IMPROVEMENT IN PSORIASIS IS ASSOCIATED WITH LONG-TERM INHIBITION OF RADIOGRAPHIC PROGRESSION. Lara D. Veeken. 48. 1 indexed citations

13.

Dougados, Maxime, Michelle P. Luo, Walter P. Maksymowych, et al.. (2008). Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial. Arthritis Care & Research. 59(4). 553–560. 33 indexed citations

14.

Haibel, Hildrun, Martín Rudwaleit, Joachim Listing, et al.. (2008). Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two. Arthritis & Rheumatism. 58(7). 1981–1991. 231 indexed citations

15.

Ward, Thomas N., Morris Levin, & Robert Wong. (2004). Headache caused by giant cell arteritis. Current Treatment Options in Neurology. 6(6). 499–505. 12 indexed citations

16.

Kahan, Barry D., et al.. (1999). A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2. Transplantation. 68(8). 1100–1106. 86 indexed citations

17.

Cooney, Gerard F., Stephen P. Dunn, John F. Sommerauer, et al.. (1999). Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation. Liver Transplantation and Surgery. 5(2). 112–118. 8 indexed citations

18.

Pescovitz, Mark D., Gary W. Barone, Miles G. Choc, et al.. (1997). SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE: TWO-YEAR DATA IN PRIMARY RENAL ALLOGRAFT RECIPIENTS. Transplantation. 63(5). 778–780. 18 indexed citations

19.

Chan‐Yeung, Moira, Robert Wong, L MacLean, et al.. (1983). Epidemiologic Health Study of Workers in an Aluminum Smelter in British Columbia. American Review of Respiratory Disease. 127(4). 465–469. 48 indexed citations

20.

Chan-Yeung, M, Robert Wong, L MacLean, et al.. (1980). Respiratory survey of workers in a pulp and paper mill in Powell River, British Columbia.. PubMed. 122(2). 249–57. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact